Dystonia in the Mohr-Tranebjaerg syndrome responds to GABAergic substances

Movement Disorders

Volumn 19, Issue 10, 2004, Pages 1241-1243

  Kreisel, Stefan H ^a   Binder, Johannes ^a   Wöhrle, Johannes C ^a   Krauss, Joachim K ^a   Hofmann, Sabine ^b   Bauer, Matthias F ^b   Hennerici, Michael G ^a   Bäzner, Hansjörg ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Academic Hospital   (Germany)

Author keywords

Deafness dystonia syndrome; GABAergic substances; Mohr Tranebjaerg syndrome

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR STIMULATING AGENT; 4 HYDROXYBUTYRIC ACID; ALCOHOL; BACLOFEN; CARBAMAZEPINE; CLOMIPRAMINE; CLONAZEPAM; LEVODOPA; MEMBRANE PROTEIN; PLACEBO; SULPIRIDE; TIAPRIDE; TRIHEXYPHENIDYL;

ADULT; ARTICLE; CASE REPORT; DYSTONIA; GENE MUTATION; HEARING IMPAIRMENT; HUMAN; MALE; MISSENSE MUTATION; NEUROLOGIC EXAMINATION; PATHOGENESIS; PRIORITY JOURNAL; SYMPTOM; TASK PERFORMANCE; TREATMENT FAILURE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL IMPAIRMENT; X CHROMOSOME LINKAGE;

ADULT; CLONAZEPAM; COGNITION DISORDERS; DYSTONIC DISORDERS; GABA MODULATORS; GENETIC DISEASES, X-LINKED; HEARING LOSS, SENSORINEURAL; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MENTAL DISORDERS; MUTATION, MISSENSE; MYOCLONUS; POINT MUTATION; SYNDROME;

EID: 7244239222     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.20150     Document Type: Article

References (11)

1. Jin H, May M, Tranebjaerg L, et al. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet 1996;14:177-180.
2. Rothbauer U, Hofmann S, Muhlenbein N, et al. Role of the deafness dystonia peptide 1 (DDP1) in import of human Tim23 into the inner membrane of mitochondria. J Biol Chem 2001;276: 37327-37334.
3. Koehler CM, Leuenberger D, Merchant S, Renold A, Junne T, Schatz G. Human deafness dystonia syndrome is a mitochondrial disease. Proc Natl Acad Sci U S A 1999;96:2141-2146.
4. Binder J, Hofmann S, Kreisel S, et al. Clinical and molecular findings in a patient with a novel mutation in the deafness-dystonia peptide (DDP1) gene. Brain 2003;126(Pt 8):1814-1820.
5. Hayes MW, Ouvrier RA, Evans W, Somerville E, Morris JG. X-linked dystonia-deafness syndrome. Mov Disord 1998;13:303-308.
6. Gasser T. Inherited myoclonus-dystonia syndrome. Adv Neurol 1998;78:325-334.
7. Priori A, Bertolasi L, Pesenti A, Cappellari A, Barbieri S. gammahydroxybutyric acid for alcohol-sensitive myoclonus with dystonia. Neurology 2000;54:1706.
8. Obeso JA, Rothwell JC, Lang AE, Marsden CD. Myoclonic dystonia. Neurology 1983;33:825-830.
9. Vitek JL. Pathophysiology of dystonia: a neuronal model. Mov Disord 2002;17(Suppl. 3):S49-S62.
10. Levy LM, Hallett M. Impaired brain GABA in focal dystonia. Ann Neurol 2002;51:93-101.
11. Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int 2002;40: 475-486.